One of the more puzzling things about Dupuytren’s is the variation in demographic data. Taking away the variation in results from different surgeons doing different operations, one would expect a

The management options for people with Dupuytren’s can appear as confusing as the biology. This review provides a nice overview of Dupuytren’s disease and a practical decision tree approach to

HH Reckeweg (1905-1985) in Germany developed the Disease Evolution Table of homeopathic medicine. In this system, Dupuytren’s contracture is classified as a mesenchymal-connective tissue cellular-degeneration phase disease. This should be